CLINICAL_TRIALS
trial_result
· 2026-03-12
Clinical Trial Update: Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP. [Phase 2]
Summary
Phase 2 clinical trial evaluating ixabepilone in metastatic breast cancer selected by the ixabepilone DRP was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allarity Therapeutics | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2026-03-12